PMGC Holdings Announces Term Sheet with Orbit2Orbit for NorthStrive Biosciences to Launch a Spaceflight Study of Its Myostatin and Activin A Assets, EL-22 and EL-32, Targeting Microgravity-Induced Muscle Loss
Globe Newswire•25/08/2026•07:30 ET
0
Whiz Insights
Get started
Create a free account to read the full story.